SpectronRx

SPECTRONRx provides therapeutic and diagnostic isotopes for clinical and research purposes. SPECTRONRx focuses on offering flexible and efficient contract manufacturing and contract research services to clients, serving as an experienced resource in the market. SPECTRONRx is an FDA-approved radiopharmaceutical manufacturer with three active ANDAs. SPECTRONRx holds an NRC license, enabling it to handle a variety of isotopes, including Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64, and Fluorine-18. The Hymon Sars Cov-2 Kit is a rapid, high-capacity real-time RT-PCR test designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper respiratory and bronchoalveolar lavage samples from individuals suspected of having COVID-19 by healthcare providers. SPECTRONRx has state-of-the-art manufacturing facilities with scalable cleanrooms, which include 6 mini hot cell rooms, 5 – ISO 5 (Class A) hot cells, and 4 – ISO 5 (Class A) shielded biosafety hoods.